Phase I dose escalation and pharmacokinetics clinical trial of mitoxantrone hydrochloride liposome in children with relapsed and refractory solid tumors.

被引：0
|
作者：
Huang, Junting
Ji, Mingqing
Li, Hui
Wu, Yanpeng
Cai, Ruiqing
Wang, Juan
Lu, Suying
Zhu, Jia
Sun, Feifei
Zhen, Zijun
Zhang, Yizhuo
机构：
[1] Sun Yat Sen Univ Canc Ctr, Guangzhou, Peoples R China
[2] Sichuan Canc Hosp, Chengdu, Peoples R China
[3] Wuhan Childrens Hosp, Wuhan, Peoples R China
[4] Fifth Affiliated Hosp, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10047
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Combination of Mitoxantrone Hydrochloride Liposome with Tislelizumab in Patients with Relapsed or Refractory NK/T Cell Lymphoma: A Phase Ib/. Clinical Trial
    Cai, Qingqing
    Xia, Yi
    Wang, Liang
    Huang, Huiqiang
    Wang, Jinni
    Cai, Jun
    Tian, Xiaopeng
    BLOOD, 2023, 142
  • [2] Phase I/II trial of vorinostat in combination with etoposide in pediatric patients with relapsed/refractory solid tumors.
    Trippett, Tanya M.
    Smith, Amy
    Neville, Kathleen
    Chi, Susan
    Narendran, Aru
    Arceci, Robert
    Direnzo, Jennifer
    Gore, Lia
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [3] Phase IB dose escalation study of bortezomib and sunitinib in patients with refractory solid tumors.
    Kauh, J. S.
    Harvey, R. D.
    Lawson, D. H.
    Owonikoko, T. K.
    Tighiouart, M.
    Ramalingam, S. S.
    Shin, D. M.
    Lewis, C. M.
    El-Rayes, B. F.
    Khuri, F. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Phase I dose-escalation study of sorafenib plus S-1 in refractory solid tumors.
    Tsai, Hui-Jen
    Chiang, Nai-Jung
    Shiah, Her-Shyong
    Chang, Kwang-Yu
    Su, Wu-Chou
    Chang, Jang-Yang
    Chen, Li-Tzong
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [5] Initial phase I trial of a new liposome-encapsulated doxorubicin formulation in patients with refractory solid tumors.
    Izquierdo, MA
    Balañá, C
    Fabregat, X
    García, M
    Martinez, M
    Llorens, MA
    Gimeno, M
    Mesia, R
    Rosell, R
    Germá, JR
    CLINICAL CANCER RESEARCH, 1999, 5 : 3795S - 3795S
  • [6] A phase I trial of vinorelbine in combination with mitoxantrone in patients with refractory solid tumors
    Peacock, NW
    Burris, HA
    Dieras, V
    Smith, L
    Rodriguez, GI
    Eckardt, JR
    Jones, SF
    Hardy, J
    Hohneker, J
    Bigley, J
    Von Hoff, DD
    INVESTIGATIONAL NEW DRUGS, 1998, 16 (01) : 37 - 43
  • [7] A phase I trial of vinorelbine in combination with mitoxantrone in patients with refractory solid tumors
    Nancy W. Peacock
    Howard A. Burris
    Veronique Dieras
    Lon Smith
    Gladys I. Rodriguez
    John R. Eckardt
    Suzanne Fields Jones
    Joanne Hardy
    John Hohneker
    Joseph Bigley
    Daniel D. Von Hoff
    Investigational New Drugs, 1998, 16 : 37 - 43
  • [8] PHASE I/II TRIAL OF MITOXANTRONE AND CLOFARABINE IN CHILDREN WITH RELAPSED/REFRACTORY ACUTE LEUKEMIA
    Hochberg, Jessica
    Oesterheld, Javier
    Gardenswartz, Aliza
    Klejmont, Liana
    Harrison, Lauren
    Basso, Jaclyn
    Borowitz, Michael
    Loken, Michael
    Cairo, Mitchell
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [9] Phase I clinical trial of oxaliplatin in children and adolescents with refractory solid tumors
    Spunt, Sheri L.
    Freeman, Burgess B., III
    Billups, Catherine A.
    McPherson, Valerie
    Khan, Raja B.
    Pratt, Charles B.
    Stewart, Clinton E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (16) : 2274 - 2280
  • [10] Phase I dose escalation and pharmacokinetic study of oral gefitinib and irinotecan in children with refractory solid tumors
    R. C. Brennan
    W. Furman
    S. Mao
    J. Wu
    D. C. Turner
    C. F. Stewart
    V. Santana
    L. M. McGregor
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 1191 - 1198
12345